- JP-listed companies
- TRANS GENIC GROUP INC.
- Income statement
TRANS GENIC GROUP INC.【JP:2342】Income statement
Market cap
¥4.8B
P/E ratio
117.1x
Transgenics Group supports drug development through specialized lab services like genetically modified mice production and pharmaceutical testing, while also providing business consulting and importing various products from electrical equipment to tableware.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 608 | 704 | 1,618 | 1,959 | 2,290 | 2,303 | 3,601 | 8,675 | 11,047 | 11,046 | 12,577 | 11,430 | 13,083 | 13,005 |
| Revenue growth (%) | - | - | ||||||||||||
| Cost of revenue | - | - | - | 1,302 | 1,618 | 1,554 | 2,779 | 7,176 | 9,267 | 8,269 | 8,741 | 9,435 | 10,834 | 10,838 |
| Gross profit | - | - | - | 657 | 673 | 749 | 822 | 1,498 | 1,780 | 2,777 | 3,836 | 1,995 | 2,249 | 2,167 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating margin (%) | - | - | - | |||||||||||
| Operating expenses | - | - | - | 633 | 622 | 595 | 762 | 1,228 | 1,606 | 1,884 | 1,999 | 2,020 | 2,160 | 2,426 |
| Operating income | - | - | - | 24 | 50 | 154 | 61 | 270 | 174 | 893 | 1,837 | -25 | 89 | -260 |
| Income before tax | -120 | -32 | -122 | 9 | 19 | 88 | 14 | 256 | 95 | 892 | 1,819 | 199 | 108 | -320 |
| Pretax margin (%) | -19.8 | -4.5 | -7.6 | 0.5 | 0.8 | 3.8 | 0.4 | 3 | 0.9 | 8.1 | 14.5 | 1.7 | 0.8 | -2.5 |
| Provision for income taxes | - | - | - | -3 | 4 | 1 | -6 | 1 | 191 | 153 | 908 | 108 | 39 | 415 |
| Effective tax rate (%) | - | - | - | |||||||||||
| Net income | -162 | 19 | -102 | 18 | 15 | 81 | 21 | 202 | -441 | 546 | 1,876 | -410 | 4 | -1,090 |
| Net income margin (%) | ||||||||||||||
| Earnings per share | -12.06 | 2.09 | -8.39 | 1.29 | 1.05 | 5.63 | 1.41 | 11.95 | -25.38 | 31.45 | 109.52 | -24.32 | 0.24 | -65.51 |
| Diluted EPS | - | 2.08 | - | 1.29 | 1.05 | 5.62 | 1.39 | 11.91 | - | 31.45 | 109.31 | - | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Dividend per share | - | - | - | - | - | - | - | - | - | 3 | 6 | 5 | 3 | - |
| EBITDA | - | - | - | |||||||||||
| EBITDA margin (%) | - | - | - |